✦ LIBER ✦

Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis

✍ Scribed by W. WEIMAR; R. A. HEIJTINK; S. W. SCHALM; H. SCHELLEKENS

Book ID: 114726031
Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 362 KB
Volume: 9
Category: Article
ISSN: 0014-2972
DOI: 10.1111/j.1365-2362.1979.tb01682.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FIBROBLAST INTERFERON IN HBsAg-POSITIVE

FIBROBLAST INTERFERON IN HBsAg-POSITIVE CHRONIC ACTIVE HEPATITIS

✍ Weimar, W.; Heijtink, R.A.; Schalm, S.W.; Van Blankenstein, M.; Schellekens, H.; 📂 Article 📅 1977 🏛 The Lancet 🌐 English ⚖ 157 KB

DOUBLE-BLIND STUDY OF LEUCOCYTE INTERFER

DOUBLE-BLIND STUDY OF LEUCOCYTE INTERFERON ADMINISTRATION IN CHRONIC HBsAg-POSITIVE HEPATITIS

✍ Weimar, W; Ten Kate, F.J.P; Masurel, N; Heijtink, R.A; Schalm, S.W; Schellekens, 📂 Article 📅 1980 🏛 The Lancet 🌐 English ⚖ 374 KB

Influenza vaccination in HBsAg positive

Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon

✍ R. A. Heijtink; N. Masurel; W. Weimar; S. W. Schalm 📂 Article 📅 1980 🏛 Springer-Verlag 🌐 English ⚖ 368 KB

Treatment of hepatitis B surface antigen

Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant leucocyte α-A interferon

✍ Hess, Georg; Gerlich, Wolfram; Slusarczyk, Janusz; Hütteroth, Thomas H.; Meyer z 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Lack of in vivo activation of the interf

Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis

✍ Alain Poitrine; Suzanne Chousterman; Michel Chousterman; Sylvie Naveau; Ming Ngu 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

The in uivo activation state of the interferon system was biochemically evaluated in patients with HBsAg-positive liver disease by assaying the interferon-induced enzyme, 2 '5 ' -01igoadenylate synthetase, in peripheral blood mononuclear cells. All patients with chronic active hepatitis had normal l

Combined interferon alpha, corticoid wit

Combined interferon alpha, corticoid withdrawal and acyclovir therapy in the treatment of HBsAg positive active chronic hepatitis

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 107 KB